A novel effect of insulin on vascular smooth muscle cells through the transcriptional regulation ?the meaning of the activation of C/EBP

胰岛素通过转录调控对血管平滑肌细胞的新作用——C/EBP激活的意义

基本信息

  • 批准号:
    14571090
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2003
  • 项目状态:
    已结题

项目摘要

Phosphatidylinositol 3-kinase (PI 3-kinase is a key molecule mediating signals of insulin in vascular smooth muscle cells (VSMCs). To examine the-effect of chronic activation of PI 3-kinase on the gene expression of VSMCs, membrane-targeted p110CAAX, a catalytic subunit of PI 3-kinase, was o overexpressed m rat SMCs by adenovirus-mediated gene transfer. Similar to insulin' s effects, cells overexpressing p110CAAX exhibited 10-to 15-fold increase in monocyte chemoattractant protein-1 (MCP-1) mRNA expression as compared with the control cells. Electrophoretic mobility shift assay showed that the overexpression of p110CAAX activated neither the NF-κB binding nor the activator protein (AP-1) binding activities. To investigate the mechanisms for the induction of MCP-1 gene expression by p110CAAX, 3.6 kb of the upstream region of MCP-1 gene was cloned and the promoter activity was analyzed by luciferase reporter assay. We found that two CCAAT/enhancer binding protein (C/EBP) binding sites located between 2.6 and 3.6 kb upstream of the MCP-1 gene were responsible for the induction by p110CAAX. The overexpression of C/EBP-β and C/EBP-δ but not C/EBP-α caused 6-to 8-fold induction of MCP-1 promoter activity. Consistently, the overexpression of p110CAAX induced mRNA expression and nuclear expression of CIEBP-β and C/EBP-δ in VSMCs. Insulin at 1 to 10 nM also increased nuclear expression of C/EBP-βand C/EBP-δ in VSMCs. These results clearly indicate that the activation of PI 3-kinase induced proinflammatory gene expression through activating C/EBP-β and CIEBP-δ but not NF-κB, which may explain the proinflammatory effect of insulin in the insulin-resistant state.
磷脂酰肌醇3-激酶(PI 3-激酶)是血管平滑肌细胞中介导胰岛素信号的关键分子。为了研究PI 3激酶的慢性激活对VSMCs基因表达的影响,通过腺病毒介导的基因转移,膜靶向p110CAAX (PI 3激酶的催化亚基)在大鼠SMCs中过表达。与胰岛素的作用类似,过表达p110CAAX的细胞单核细胞趋化蛋白-1 (MCP-1) mRNA的表达比对照细胞增加了10- 15倍。电泳迁移率转移实验表明,p110CAAX过表达既没有激活NF-κB结合,也没有激活激活蛋白(AP-1)的结合活性。为了研究p110CAAX诱导MCP-1基因表达的机制,我们克隆了MCP-1基因上游3.6 kb片段,并利用荧光素酶报告基因法分析了启动子活性。我们发现两个CCAAT/增强子结合蛋白(C/EBP)结合位点位于MCP-1基因上游2.6 - 3.6 kb之间,与p110CAAX诱导有关。C/EBP-β和C/EBP-δ过表达,而C/EBP-α不表达,可诱导MCP-1启动子活性达到6 ~ 8倍。同样,p110CAAX过表达诱导VSMCs中CIEBP-β和C/EBP-δ的mRNA表达和核表达。胰岛素在1 ~ 10 nM也增加了VSMCs中C/EBP-β和C/EBP-δ的核表达。这些结果清楚地表明,PI 3激酶的激活通过激活C/EBP-β和CIEBP-δ而不是NF-κB来诱导促炎基因的表达,这可能解释了胰岛素抵抗状态下胰岛素的促炎作用。

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shimizu S, Ugi S, Maegawa H et al.: "Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis viasterol regulatory element-binding protein-1 gene expression"J Bilol Chem. 278. 43095-43101 (2003)
Shimizu S、Ugi S、Maekawa H 等人:“蛋白质酪氨酸磷酸酶 1B 作为肝脂肪生成维甾醇调节元件结合蛋白 1 基因表达的新激活剂”J Bilol Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sekine O, Nishio Y, Egawa K et al.: "Insulin acrivtes CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth moscle cells"The Journal of Biological Chemistry. 277. 36631-366
Sekine O、Nishio Y、Egawa K 等人:“血管平滑肌细胞中通过磷脂酰肌醇 3-激酶途径实现胰岛素促 CCAAT/增强子结合蛋白和促炎基因表达”《生物化学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sekine O, Nishio Y, Egawa K et al.: "Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells."J Biol Chem. 277. 36631-36639 (2002)
Sekine O、Nishio Y、Egawa K 等人:“胰岛素通过血管平滑肌细胞中的磷脂酰肌醇 3-激酶途径激活 CCAAT/增强子结合蛋白和促炎基因表达。”J Biol Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nagai Y,.Nishio Y, Nakamura T et al.: "Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha"Am J Physiol Endocrinol Metab. 282. E1180-E1190 (2002)
Nagai Y、Nishio Y、Nakamura T 等人:“通过激活 PPARα 改善高果糖诱导的代谢紊乱”Am J Physiol Endocrinol Metab。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nagai Y, Nishio Y, Nakamura T et al.: "Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha"American Journal Physiology, Endocrinolgy and Metabolism. 282. 1180-1190 (2002)
Nagai Y、Nishio Y、Nakamura T 等人:“通过激活 PPARα 改善高果糖诱导的代谢紊乱”美国生理学、内分泌和代谢杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NISHIO Yoshihiko其他文献

NISHIO Yoshihiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NISHIO Yoshihiko', 18)}}的其他基金

The effects of omega-3 PUFA on vascular function
omega-3 PUFA 对血管功能的影响
  • 批准号:
    23591336
  • 财政年份:
    2011
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification and characterization of a new factor regulating SREBP-1c gene in liver.
肝脏中 SREBP-1c 基因调节新因子的鉴定和表征。
  • 批准号:
    20591058
  • 财政年份:
    2008
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the mechanism for the activation of transcription factors and gene response in the aorta of the Postprandial state of rata
阐明大鼠餐后状态主动脉转录因子激活和基因反应的机制
  • 批准号:
    18590981
  • 财政年份:
    2006
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of the inhibitory factor for the transcription of inflammatory genes in vascular smooth muscle cells
血管平滑肌细胞炎症基因转录抑制因子的鉴定
  • 批准号:
    16590877
  • 财政年份:
    2004
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of oxidative stress related genes and transcription factors in vascular tissues
血管组织中氧化应激相关基因和转录因子的鉴定
  • 批准号:
    11671112
  • 财政年份:
    1999
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

PI3 Kinase Inactivation in Myelodysplastic Syndrome
骨髓增生异常综合征中的 PI3 激酶失活
  • 批准号:
    10518821
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
PI3 Kinase Inactivation in Myelodysplastic Syndrome
骨髓增生异常综合征中的 PI3 激酶失活
  • 批准号:
    10669279
  • 财政年份:
    2022
  • 资助金额:
    $ 2.24万
  • 项目类别:
PI3 Kinase Inactivation in Myelodysplastic Syndrome
骨髓增生异常综合征中的 PI3 激酶失活
  • 批准号:
    10476196
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Targeting PI3-kinase p110delta to treat Crohn's disease-associated intestinal fibrosis
靶向 PI3 激酶 p110delta 治疗克罗恩病相关肠纤维化
  • 批准号:
    401340
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
Development of a Dual and Selective Small Molecule Inhibitor of EGFR and PI3 Kinase to Treat BRAF Mutant Colorectal Cancer
开发 EGFR 和 PI3 激酶双重选择性小分子抑制剂来治疗 BRAF 突变结直肠癌
  • 批准号:
    10377535
  • 财政年份:
    2018
  • 资助金额:
    $ 2.24万
  • 项目类别:
Development of a Dual and Selective Small Molecule Inhibitor of EGFR and PI3 Kinase to Treat BRAF Mutant Colorectal Cancer
开发 EGFR 和 PI3 激酶双重选择性小分子抑制剂来治疗 BRAF 突变结直肠癌
  • 批准号:
    9896781
  • 财政年份:
    2018
  • 资助金额:
    $ 2.24万
  • 项目类别:
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
膜运输和代谢中的 PI3 激酶 PIK3CB (p110beta)
  • 批准号:
    10001471
  • 财政年份:
    2018
  • 资助金额:
    $ 2.24万
  • 项目类别:
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
膜运输和代谢中的 PI3 激酶 PIK3CB (p110beta)
  • 批准号:
    10474502
  • 财政年份:
    2018
  • 资助金额:
    $ 2.24万
  • 项目类别:
PI3 kinase PIK3CB (p110beta) in membrane trafficking and metabolism
膜运输和代谢中的 PI3 激酶 PIK3CB (p110beta)
  • 批准号:
    10249278
  • 财政年份:
    2018
  • 资助金额:
    $ 2.24万
  • 项目类别:
Endothelial Healing is Inhibited by PI3 Kinase-Induced Activation of TRPC6
PI3 激酶诱导的 TRPC6 激活抑制内皮愈合
  • 批准号:
    10265334
  • 财政年份:
    2017
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了